Table 2.
Author | Initial diagnosis | Method of diagnosis | Mimic type |
---|---|---|---|
Diogo Costa et al. 5 | nm | nm | 31% autoimmune encephalitis,2% anti-NMDA receptor encephalitis66% non-autoimmune encephalitis |
Flanagan et al. 12 | nm | 16% biopsy,2.8% genetic testing,1.8% infectious testing,84.1% laboratory testing and imaging | nm |
Budhram et al. 13 | autoimmune encephalitis | VDRL test | autoimmune encephalitis |
Thomas et al. 14 | anti-LGI1 limbic encephalitis | biopsy | limbic encephalitis |
Zuhorn et al. 15 | autoimmune encephalitis | biopsy | autoimmune encephalitis with CASPR2 antibodies |
Lu et al. 16 | anti-NMDA receptor encephalitis | surgical biopsy of the right parietal lesion | anti-NMDA receptor encephalitis |
Van Steenhoven et al. 18 | nm | brain MRI suggestive of AIE, CSF pleocytosis, specific oligoclonal bands in CSF, repeated steroid responsiveness, or similar staining pattern on IHC in serum and CSF in the absence of a known neuronal autoantibody | nm |
AbdeleRahman et al. 19 | mesial temporal encephalitis | VDRL | mesial temporal encephalitis |
Vogrig et al. 20 | antibody-negative autoimmune encephalitis | brain biopsy | antibody-negative autoimmune encephalitis |
autoimmune encephalitis | brain biopsy | autoimmune encephalitis | |
HSV and autoimmune encephalitis | brain biopsy | autoimmune encephalitis | |
autoimmune encephalitis | brain biopsy | autoimmune encephalitis | |
nm | brain biopsy | nm | |
nm | brain biopsy | nm | |
Macchia et al. 21 | autoimmune limbic encephalitis | MRI | autoimmune limbic encephalitis |
Badruddin et al. 25 | their DDX: HSV encephalitis – limbic encephalitis – Morvan syndrome | clinical history | autoimmune-mediated limbic encephalitis |
Devamare et al. 26 | viral encephalitis and anti-NMDA receptor encephalitis | nm | anti-NMDA receptor encephalitis |
Garg et al. 27 | autoimmune encephalitis | nm | autoimmune encephalitis |
Harsha et al. 28 | autoimmune encephalitis and paroxysmal kinesiogenic dyskinesia | clinical history | autoimmune encephalitis |
Poon et al. 29 | autoimmune, infectious encephalitis | morning cortisol | autoimmune encephalitis or infectious encephalitis |
Rigoni et al. 30 | autoimmune encephalitis | biopsy | autoimmune encephalitis |
Wiels et al. 31 | progressive encephalomyelitis with rigidity and myoclonus with anti-glycine receptor antibodies | biopsy | progressive encephalomyelitis with rigidity and myoclonus |
Nagata et al. 32 | limbic encephalitis | neuropathological diagnosis | limbic encephalitis |
M Khair et al. 33 | autoimmune encephalitis | by the diagnostic criteria of common variable immunodeficiency | autoimmune encephalitis |
Serrano-Cardenas et al. 34 | mesial encephalitis | microbiological studies | mesial encephalitis |
Blondin et al. 35 | limbic encephalitis | CT, MRI, histological analysis | limbic encephalitis |
Scheid et al. 36 | paraneoplastic limbic encephalitis | VDRL test | paraneoplastic limbic encephalitis |
Deramecourt et al. 37 | paraneoplastic limbic encephalitis with pure cognitive impairment | MRI and stereotactic biopsies | paraneoplastic limbic encephalitis |
Piola et al. 38 | anti-NMDA receptor encephalitis | CT scan, surgical monitoring of intracranial pressure, brain angiography, and autopsy | anti-NMDA receptor encephalitis |
Liao et al. 39 | anti-LGI1 encephalitis | rapid plasma reagin and Treponema pallidum particle agglutination | anti-LGI1 encephalitis |
Gajurel et al. 40 | autoimmune encephalitis | lip biopsy for mucosal lymphocytic infiltrates | autoimmune encephalitis |
Kimura et al. 41 | anti-NMDA receptor encephalitis | clinically | anti-NMDA receptor encephalitis |
Consoli et al. 42 | acute disseminated encephalomyelitis | brain biopsy | acute disseminated encephalomyelitis |
rhombencephalitis | brain biopsy | rhombencephalitis |
DDX, differential diagnosis; HSV, herpes simplex virus; VDRL, venereal disease research laboratory; NMDA, N-methyl-D-aspartate; nm, not mentioned; MRI, magnetic resonance imaging; CT, computed tomography; AIE, autoimmune encephalitis; CSF, cerebrospinal fluid; IHC, immunohistochemistry.